Gyre Therapeutics (GYRE) Return on Sales Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.00 |
| Dec 31, 2025 | 9.00 |
| Sep 30, 2025 | 18.00 |
| Jun 30, 2025 | 10.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2023 | 5,407.00 |
| Sep 30, 2023 | 78.00 |
| Jun 30, 2023 | 36.00 |
| Mar 31, 2023 | 841.00 |
| Dec 31, 2022 | 18.00 |
| Sep 30, 2022 | 22.00 |
| Jun 30, 2022 | 52.00 |
| Mar 31, 2022 | -3.00 |
| Dec 31, 2021 | 44.00 |
| Sep 30, 2021 | 33.00 |
| Jun 30, 2021 | 27.00 |
| Mar 31, 2021 | 18.00 |
| Dec 31, 2020 | 50.00 |
| Sep 30, 2020 | 15.00 |
| Jun 30, 2020 | -5.00 |
| Mar 31, 2020 | 10.00 |
| Dec 31, 2018 | -5,267.00 |
| Sep 30, 2018 | -66.00 |
| Jun 30, 2018 | -27.00 |
| Mar 31, 2018 | -838.00 |
| Dec 31, 2017 | 8.00 |
| Sep 30, 2017 | -8.00 |
| Jun 30, 2017 | -54.00 |
| Mar 31, 2017 | -15.00 |
| Dec 31, 2016 | -52.00 |
| Sep 30, 2016 | -43.00 |
| Jun 30, 2016 | -44.00 |
| Mar 31, 2016 | -33.00 |
| Dec 31, 2015 | -60.00 |
| Sep 30, 2015 | -51.00 |
| Jun 30, 2015 | -24.00 |